Skip to main content
. 2020 Jul 30;3(5):813–834. doi: 10.1021/acsptsci.0c00074

Figure 2.

Figure 2

Distribution of SARS-, MERS-, and COVID-19-associated documents and potential therapeutic substances in relation to specific targets.